Form 4: NVCR CFO holdings now 134,117 shares after RSU tax
Rhea-AI Filing Summary
NovoCure Ltd. (NVCR) reported an insider transaction on Form 4 for its Chief Financial Officer. On 11/04/2025, 7,033 ordinary shares were withheld at $12.23 to satisfy tax obligations from the vesting of Restricted Stock Units. Following this withholding (transaction code F), the CFO directly holds 134,117 shares. The filing notes the action was not discretionary and was approved pursuant to Rules 16b-3(e) and 16b-3(d)(1).
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 7,033 shares
Net Sell
1 txn
Insider
Brackmann Christoph
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Ordinary Shares | 7,033 | $12.23 | $86K |
Holdings After Transaction:
Ordinary Shares — 134,117 shares (Direct)
Footnotes (1)
- F1. Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).
FAQ
What did NovoCure (NVCR) disclose in this Form 4?
The CFO had 7,033 shares withheld at $12.23 on 11/04/2025 to cover taxes on RSU vesting (code F).
Who is the reporting person in NVCR’s Form 4?
The reporting person is NovoCure’s Chief Financial Officer.
What does transaction code F mean on a Form 4?
Code F indicates shares withheld to pay taxes in connection with equity award vesting.
Was the NVCR CFO’s transaction discretionary?
No. The filing states it was not discretionary and approved under Rules 16b-3(e) and 16b-3(d)(1).
AI-generated analysis. How Rhea-AI works. Not financial advice.